Storys zum Thema Medizinische Forschung

Bosch Healthcare Solutions GmbH

Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes

Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade test. Bosch has agreed on a strategic partnership with Randox ...

Helmholtz Munich

Scientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets

Helmholtz Munich

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

PNO Innovation GmbH

iMEDCAP: EU-Projekt leistet Pionierarbeit bei der Rettung verwundeter Soldaten

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

Helmholtz Munich

What Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications

PNO Innovation GmbH

2

OPTIMA cancer project announces the Region Uppsala as new partner

Helmholtz Munich

New Source of Stem Cells in Injury-Affected Brains of Patients

Fraunhofer-Institut für Produktionstechnologie IPT

Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems

PNO Innovation GmbH

2

PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHub

PNO Innovation GmbH

3

EU Provides 1 Mio. to Researchers to Advance Personalised Oncology

PNO Innovation GmbH

canSERV Releases Open Call for Transnational Service Provision

Helmholtz Munich

Interpreting Large-Scale Medical Datasets: ScPoli Enables Multi-Scale Representations of Cells and Samples

The increasing amount of data recorded in medical research can only lead to scientific breakthroughs and essential therapies for patients if interpreted and analyzed correctly. Computer scientists at Helmholtz Munich developed a generative model named scPoli (single-cell population level integration), that performs ...

Helmholtz Munich

A New Ally in Fighting Brain Diseases: Our Very Own Skull

PNO Innovation GmbH

4

PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data Sets

Helmholtz Munich

Life Science Factory to Open a New Location in Munich in 2024

Medias Klinikum GmbH & Co KG

The Medias Hospital is Raising the Bar for Interventional Oncology as an IASIOS Enrolled Centre

Burghausen/Germany (ots) - The Medias Hospital has officially enrolled in the accreditation program of IASIOS to further ensure highest quality standards in Interventional Oncology as an important aspect of oncological patient care. The Medias Hospital has taken the next step to committing to the highest standards when it comes to interventional oncology (IO) care and ...

eleva GmbH

Björn Cochlovius New CEO of Eleva / Seasoned Molecular Biologist and Entrepreneur Leads German Biotech Company into its Next Development

Freiburg, Germany (ots) - Björn Cochlovius Ph.D. has become the new CEO of Eleva, a Freiburg-based biotech company and the developer of “Bryotechnology”, a unique and pioneering process for the moss-based production of complex therapeutic proteins. The renowned oncologist, immunologist, and molecular biologist ...

Technische Universität München

Nanoswitches for tumor targeting

TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Video: https://www.youtube.com/watch?v=_xXV0mCke1g NEWS RELEASE Nanoswitches for tumor targeting TUM spin-off Plectonic develops antibody-based immunotherapies Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of ...

Technische Universität München

Tumors: forecasting the risks of brain surgery

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 18198 - email: presse@tum.de - web: www.tum.de This text on the web: http://go.tum.de/619311 Pictures: http://go.tum.de/010709 - http://go.tum.de/959985 - http://go.tum.de/098359 - http://go.tum.de/754050 - http://go.tum.de/109729 Accurately predicting possible post-surgical effects on speech Tumors: forecasting the risks of brain surgery ...

RHEACELL GmbH und Co. KG

Stem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research

Technische Universität München

Viruses help combat antibiotic-resistant bacteria - Cell-free production of bacteriophages

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37533 High resolution images: https://mediatum.ub.tum.de/1678288 NEWS RELEASE Viruses help combat ...

Technische Universität München

New center for digital medicine and health

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37491 Images: https://mediatum.ub.tum.de/1663381 NEWS RELEASE Interdisciplinary research for the digital medicine of the future Federal and state governments approve funding for digital medicine and health center ...

News Direct

ALDERHEY@NYWHERE(TM)

Liverpool, England (ots) - CREATING A HOSPITAL OF THE FUTURE: "A HOSPITAL WITHOUT WALLS" ALDER HEY LAUNCHES GROUND-BREAKING HYBRID DIGITAL HEALTH PLATFORM IN COLLABORATION WITH MICROSOFT AND MINDWAVE "TODAY'S CHILD, TOMORROW'S HEALTHIER ADULT" Alder Hey Children's NHS Foundation Trust, one of the world's leading paediatric healthcare institutions, has today launched a ground-breaking digital platform that is set to revolutionise the way in which patient care is delivered to ...